Differential diagnosis of thrombotic microangiopathy in nephrology
Abstract Background The differential diagnosis of thrombotic microangiopathy (TMA) is complex however the rapid diagnosis of the underlying condition is vital to inform urgent treatment decisions. A survey was devised with the objective of understanding current practices across Europe and the Middle...
Main Authors: | T. Sakari Jokiranta, Ondrej Viklicky, Saleh Al Shorafa, Rosanna Coppo, Christoph Gasteyger, Manuel Macia, Tatiana Pankratenko, Mohan Shenoy, Oğuz Soylemezoglu, Michel Tsimaratos, Jack Wetzels, Hermann Haller |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-017-0727-y |
Similar Items
-
Treatment of Chemotherapy-Induced Thrombotic Microangiopathy with Eculizumab in a Patient with Metastatic Breast Cancer
by: Martin Hausberg, et al.
Published: (2019-01-01) -
ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies
by: Galit Sarig
Published: (2014-10-01) -
Extrarenal manifestations of complement mediated thrombotic microangiopathies
by: Johannes eHofer, et al.
Published: (2014-09-01) -
An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry
by: Len Woodward, et al.
Published: (2016-11-01) -
Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality
by: Gianluigi Ardissino, et al.
Published: (2021-06-01)